Arasani, Norhelen E.

HRN: 21-37-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2022
CEFUROXIME 1.5GM (VIAL)
05/11/2022
05/11/2022
IV
1.5mg
Once
UTI, Ascariasis
Waiting Final Action 
05/11/2022
CEFUROXIME 750MG (VIAL)
05/11/2022
05/17/2022
IV
750mg
Q8H
UTI, Ascariasis
05/12/2022
CEFTRIAXONE 1G (VIAL)
05/12/2022
05/18/2022
IV
2g
OD
UTI; Ascariasis
Waiting Final Action 
05/16/2022
CEFIXIME 200MG (CAP)
05/16/2022
05/19/2022
ORAL
500mg
BID
TC Liver Pathology
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: